STAT3 and colorectal cancer: In the current study, the underlying antitumor mechanism of ursolic acid was examined in association with miR-4500 and STAT3 signaling in HCT116 and HT29 colorectal cancer cells, since colorectal cancers comprise a group of molecularly heterogeneous diseases that undergo a variety of clinical courses and possess diverse therapeutic responses [30,31].